This new version introduces advanced features aimed at providing nuisance alarm elimination and autonomous perimeter ...
PureTech thinks the ‘hub-and-spoke’ startup model is still a good bet. If only investors agreed.
Bristol Myers Squibb recently acquired Karuna for $14 billion. PureTech Health, the Boston-based incubator that got the company off the ground with about $19 million, has now recorded more than $1 ...
PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad ...
US biotech PureTech Health is to develop therapies that are based on a new theory that neurological diseases such as Alzheimer’s are linked to drainage issues in the brain. This revolutionary ...
Highlights,Seaport Therapeutics has successfully closed a $225 million Series B financing round, increasing total capital ...
Former ImmunoGen CFO will join Seaport to steer capital financing strategy, accounting, FP&A and investor relations PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a ...
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded ...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...
PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback